Davis Polk is advising ChipMOS TECHNOLOGIES INC. (“ChipMOS Taiwan”) in connection with its proposed merger with its parent company, ChipMOS TECHNOLOGIES (Bermuda) LTD. (“ChipMOS Bermuda”),…
Davis Polk advised Nippon Life Insurance Company on a Rule 144A/Regulation S offering of $1.5 billion aggregate amount of 4.70% step-up callable subordinated notes due 2046.
Nippon…
Davis Polk advised the dealer manager for General Electric Company (“GE”) in connection with the offer by GE to exchange up to 5,944,250 new shares of its Series D preferred stock for…
Davis Polk advised the underwriters in connection with the offering of $2.5 billion aggregate principal amount of 1.625% bonds due January 18, 2019, issued by the Province of Ontario.
The…
Davis Polk advised the managers on a Rule 144A/Regulation S offering by Crédit Agricole S.A. (“Crédit Agricole”) of $1.25 billion aggregate principal amount of undated deeply subordinated…
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by TTX Company of $300 million aggregate principal amount of its 2.250%…
Davis Polk is advising Biotie Therapies Corp. in connection with its combination agreement with Acorda Therapeutics, Inc. where Acorda will make a public tender offer in Finland and the…
Davis Polk advised Sumitomo Mitsui Banking Corporation in connection with a medium-term note program update and a benchmark takedown, which consisted of $750 million aggregate principal…
Davis Polk advised the initial purchasers of a Regulation S offering of high-yield notes by Evergrande Real Estate Group Limited of $300 million aggregate principal amount of its 8.0%…
Davis Polk is advising the dealer managers in connection with cash tender offers by ERP Operating Limited Partnership, an operating partnership subsidiary of Equity Residential (the …